This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
04/21/15 - 8:33:55 AM ET (BATS BZX Real-time Price)
Div Yield: --
ALNY Day's Range
ALNY 52 Week Range
ALNY Business Summary
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference.View ALNY key stats
Alnylam Pharmaceuticals Inc - ALNY - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Alnylam Pharmaceuticals Inc as a
Sell with a ratings score of D.
Report Snippet: We rate ALNYLAM PHARMACEUTICALS INC (ALNY) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and weak operating cash flow.